Artimplant Interim Report Jan 1 - March 31, 2003

ARTIMPLANT INTERIM REPORT JANUARY 1 - MARCH 31, 2003 DISTRIBUTION AGREEMENT FOR ARTELON(TM) AUGMENTATION DEVICE ACL Artimplant and Atlantech Ltd. - a subsidiary of ArthroCare Corporation, Sunnyvale, CA -has signed an initial distribution agreement in which Atlantech will conduct test sales during six month of Artelon(TM) Augmentation Device ACL. The restructuring program has turned out according to plan, and significantly reduced losses. The parent company's operating result, excluding share of subsidiary's earnings, totaled SEK -6,7 million (SEK -13,8 million). Gothenburg Medical Center is developing according to plan, and generated an operating profit of SEK 0,7 million. After the end of the period the Company completed the second of two share issues, which altogether brought a total of SEK 44 million. Forthcoming financial reports: January-June 2003 report: August 29, 2003 January-September 2003 report: November 7, 2003 Financial reports are available at www.artimplant.se at the same time that they're distributed to the media. For information about Business Model, Technology and Products, please see Artimplants annual report 2002, which is available in PDF-format at the Company's website. For more information, contact: Tord Lendau, CEO, +46 708 369 403, tord.lendau@artimplant.se Ulf Åkerblom, IR, +46 709 675 999, ulf.akerblom@artimplant.se Jonas Ström, CFO, +46 70 301 6854, jonas.strom@artimplant.se ARTIMPLANT Artimplant is a biomaterial company that focuses on orthopedic surgery solutions. The company runs R&D operations for biodegradable implants and develops manufacturing processes for the implants. Its goal is to enable active lives. Artimplant's biomaterial is based on a new technology that's opening new markets within orthopedic surgery and closely related areas that have extensive med-tech needs. Artimplant developed and patented several different degradable ligament implants that are now in clinical trials. The company's business concept is to license products and technologies to global partners. The Artimplant share is listed on the Stockholm stock exchange's O list. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/04/30/20030430BIT00050/wkr0001.doc The full report http://www.waymaker.net/bitonline/2003/04/30/20030430BIT00050/wkr0002.pdf The full report